Biomark Diagnostics Inc. (CSE:BUX)
Canada
· Delayed Price · Currency is CAD 0.3550
0.00 (0.00%)
Aug 15, 2025, 10:10 AM EDT
Biomark Diagnostics Revenue
In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K CAD, down -5.52%. Biomark Diagnostics had revenue of 38.99K in the quarter ending March 31, 2025, a decrease of -2.04%.
Revenue
154.22K
Revenue Growth
-5.52%
P/S Ratio
215.89
Revenue / Employee
n/a
Employees
n/a
Market Cap
33.29M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| Green Thumb Industries | 1.57B |
| Trulieve Cannabis | 1.62B |
| Sienna Senior Living | 929.68M |
| dentalcorp Holdings | 1.62B |
| Cronos Group | 177.69M |
| WELL Health Technologies | 1.10B |
| Extendicare | 1.51B |